ES2610469T3 - Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio - Google Patents

Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio Download PDF

Info

Publication number
ES2610469T3
ES2610469T3 ES05798488.2T ES05798488T ES2610469T3 ES 2610469 T3 ES2610469 T3 ES 2610469T3 ES 05798488 T ES05798488 T ES 05798488T ES 2610469 T3 ES2610469 T3 ES 2610469T3
Authority
ES
Spain
Prior art keywords
sublingual
treatment
zolpidem
sleep
study
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05798488.2T
Other languages
English (en)
Spanish (es)
Inventor
Anders Pettersson
Christer Nyström
Susanne Bredenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orexo AB
Original Assignee
Orexo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orexo AB filed Critical Orexo AB
Application granted granted Critical
Publication of ES2610469T3 publication Critical patent/ES2610469T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES05798488.2T 2004-10-27 2005-10-26 Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio Expired - Lifetime ES2610469T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0423800 2004-10-27
GBGB0423800.2A GB0423800D0 (en) 2004-10-27 2004-10-27 New pharmaceutical formulations
PCT/GB2005/004147 WO2006046041A1 (en) 2004-10-27 2005-10-26 New pharmaceutical formulations useful in the treatment of insomnia

Publications (1)

Publication Number Publication Date
ES2610469T3 true ES2610469T3 (es) 2017-04-27

Family

ID=33515600

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05798488.2T Expired - Lifetime ES2610469T3 (es) 2004-10-27 2005-10-26 Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio

Country Status (13)

Country Link
US (4) US9265720B2 (enExample)
EP (2) EP1807156B1 (enExample)
JP (1) JP5064226B2 (enExample)
CY (2) CY1118414T1 (enExample)
DK (2) DK2340872T3 (enExample)
ES (1) ES2610469T3 (enExample)
GB (1) GB0423800D0 (enExample)
HU (1) HUE030609T2 (enExample)
LT (2) LT1807156T (enExample)
PL (2) PL1807156T3 (enExample)
PT (2) PT1807156T (enExample)
SI (2) SI1807156T1 (enExample)
WO (1) WO2006046041A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130116378A (ko) 2004-02-17 2013-10-23 트랜스셉트 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
US20060281783A1 (en) 2005-05-25 2006-12-14 Transoral Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070287740A1 (en) 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20080132535A1 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized Zolpidem Pharmaceutical Compositions
US20100055181A1 (en) * 2006-12-18 2010-03-04 Lupin Limited Controlled release dosage forms of zolpidem
WO2008141264A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
JP5756749B2 (ja) * 2008-06-20 2015-07-29 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 直接圧縮性および迅速崩壊性錠剤マトリックス
WO2010144943A1 (en) * 2009-05-20 2010-12-23 Ozpharma Pty Ltd Buccal and/or sublingual therapeutic formulation
CN105581991A (zh) * 2015-12-28 2016-05-18 安徽省逸欣铭医药科技有限公司 一种酒石酸唑吡坦舌下片及其制备方法
KR102860999B1 (ko) 2018-10-08 2025-09-16 트로이카 파마슈티칼스 리미티드 졸피뎀 또는 이의 약제학적으로 허용되는 염의 구강점막 용액
CN111939133A (zh) * 2019-05-16 2020-11-17 鲁南制药集团股份有限公司 一种酒石酸唑吡坦片及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
SE8800080L (sv) 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
SE8803935L (sv) 1988-10-31 1990-05-01 Kabivitrum Ab Laekemedelskomposition
JPH0665103A (ja) * 1992-08-13 1994-03-08 ▲寛▼治 ▲高▼田 向精神薬のための速吸収性舌下投与製剤
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
WO2001030391A2 (en) * 1999-10-27 2001-05-03 Farmarc Nederland Bv Pharmaceutical composition containing midazolam
EP1272181A2 (en) * 2000-04-13 2003-01-08 Synthon B.V. Modified release formulations containing a hypnotic agent
CN1290525A (zh) 2000-10-10 2001-04-11 北京万全阳光医药科技有限公司 冷冻干燥的扎来普隆速溶口服组合物
US20040176359A1 (en) 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
AU2002259241B2 (en) * 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of sedative-hypnotics through an inhalation route
ATE389402T1 (de) * 2002-01-10 2008-04-15 Biovail Lab Int Srl Sedierende nicht-benzodiazepin-formulierungen
CA2478101A1 (en) 2002-03-06 2003-09-12 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablets
US20050208127A1 (en) * 2002-06-10 2005-09-22 Kazuyoshi Ogasawara Rapidly disintegrating tablet and process for producing the same
ES2199061B1 (es) 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US20050038042A1 (en) 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
CN1418631A (zh) 2002-12-19 2003-05-21 王登之 治疗失眠的佐匹克隆口腔崩解片及其制备方法
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
NZ544007A (en) * 2003-05-07 2009-05-31 Samyang Corp Highly plastic granules for making fast melting tablets
WO2005063248A1 (en) * 2003-12-22 2005-07-14 Sepracor Inc. Modafinil combination therapy for improving sleep quality
WO2005079761A1 (en) 2004-02-17 2005-09-01 Transoral Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
KR20130116378A (ko) * 2004-02-17 2013-10-23 트랜스셉트 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
CN1290525C (zh) * 2004-07-13 2006-12-20 赵余庆 一种降血糖的植物提取物及其用途

Also Published As

Publication number Publication date
PL2340872T3 (pl) 2017-12-29
JP5064226B2 (ja) 2012-10-31
PT2340872T (pt) 2017-10-06
LT2340872T (lt) 2017-09-11
GB0423800D0 (en) 2004-12-01
PL1807156T3 (pl) 2017-06-30
WO2006046041A1 (en) 2006-05-04
SI1807156T1 (sl) 2017-01-31
US20130230589A1 (en) 2013-09-05
LT1807156T (lt) 2016-12-12
EP2340872A1 (en) 2011-07-06
PT1807156T (pt) 2017-01-19
US20080311208A1 (en) 2008-12-18
HUE030609T2 (en) 2017-05-29
EP1807156B1 (en) 2016-10-12
CY1119580T1 (el) 2018-03-07
CY1118414T1 (el) 2017-06-28
DK1807156T3 (en) 2017-01-23
US20110268796A1 (en) 2011-11-03
US9597281B2 (en) 2017-03-21
US9265720B2 (en) 2016-02-23
EP1807156A1 (en) 2007-07-18
JP2008517988A (ja) 2008-05-29
US20120277261A1 (en) 2012-11-01
DK2340872T3 (en) 2017-09-18
SI2340872T1 (sl) 2017-10-30
EP2340872B1 (en) 2017-07-05

Similar Documents

Publication Publication Date Title
US8092832B2 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
US8119158B2 (en) Effervescent oral fentanyl dosage form and methods of administering fentanyl
ES2706407T3 (es) Composiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona
ES2538460T3 (es) Nueva composición farmacéutica resistente al abuso para el tratamiento de la dependencia de opioides
US9597281B2 (en) Pharmaceutical formulations useful in the treatment of insomnia
MXPA06007453A (es) Forma de dosificacion de opiaceo oral efervescente.
ES2749800T3 (es) Formulación de liberación sostenida de naltrexona
ES2614757T3 (es) Nueva composición de alfentanilo para el tratamiento del dolor agudo
ES2241803T3 (es) Forma galenica oral novedosa con liberacion prolongada de la molsidomina.
ES2642213T3 (es) Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio
CN1901890B (zh) 大体线性的泡腾口服芬太尼剂型和施用方法
MXPA06007449A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering